MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

MDT

100.99

-0.45%↓

134.88

-2.69%↓

VEEV

221.76

-1.44%↓

HQY

84.14

-2.65%↓

NEOG

9.81

-1.21%↓

Kodu・Aktsiate loetelu・Vaxart Inc

Vaxart Inc

Suletud

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Põhinäitajad
By Trading Economics
Sissetulek	6.8M -8.1M
Müük	33M 72M
Aktsiakasum	-0.04
Kasumimarginaal	-11.242
Töötajad	105
EBITDA	6.7M -5.4M

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	19. märts 2026

Turustatistika
By TradingEconomics
Turukapital	77M 168M
Eelmine avamishind	0
Eelmine sulgemishind	0

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

0.4007 / 0.4252 Toetus ja vastupanu

Vaxart Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. jaan 2026, 18:41 UTC

Tulu

SLB Readies Rapid Expansion in Venezuela -- 2nd Update

23. jaan 2026, 22:30 UTC

Market Talk

Global Equities Roundup: Market Talk

23. jaan 2026, 22:30 UTC

Market Talk

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23. jaan 2026, 22:03 UTC

Tulu

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23. jaan 2026, 21:52 UTC

Tulu

Omandamised, ülevõtmised, äriostud

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23. jaan 2026, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

23. jaan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23. jaan 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

23. jaan 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23. jaan 2026, 21:39 UTC

Tulu

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23. jaan 2026, 21:15 UTC

Omandamised, ülevõtmised, äriostud

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23. jaan 2026, 21:12 UTC

Tulu

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23. jaan 2026, 20:31 UTC

Tulu

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23. jaan 2026, 20:12 UTC

Market Talk

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23. jaan 2026, 20:07 UTC

Market Talk

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23. jaan 2026, 19:36 UTC

Market Talk

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23. jaan 2026, 19:30 UTC

Market Talk

Tulu

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23. jaan 2026, 19:18 UTC

Market Talk

Gold and Silver Step Up to More Records -- Market Talk

23. jaan 2026, 19:15 UTC

Tulu

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 4th Update

23. jaan 2026, 18:53 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 411 -- Market Talk

23. jaan 2026, 18:21 UTC

Tulu

Week's Best: Schwab's Assets and Profits Keep Climbing -- Barrons.com

23. jaan 2026, 18:19 UTC

Market Talk

Intel Seen as Increasingly Confident on Demand -- Market Talk

23. jaan 2026, 17:59 UTC

Tulu

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 3rd Update

23. jaan 2026, 17:57 UTC

Market Talk

Intel Could Sign Deals With Big Tech Players for 14A -- Market Talk

23. jaan 2026, 17:57 UTC

Market Talk

Global Equities Roundup: Market Talk

23. jaan 2026, 17:34 UTC

Market Talk

Tulu

Intel's Supply Challenges Seen Benefiting AMD -- Market Talk

23. jaan 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

23. jaan 2026, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

23. jaan 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

23. jaan 2026, 17:13 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Vaxart Inc Prognoos

Hinnangu Konsensus

By TipRanks

0 ratings

Osta

Hoia

Müü

Põhineb 0 analüütiku instrumendi Vaxart Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.4007 / 0.4252Toetus ja vastupanu

Recent bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.